Japan Market Reports Japan Gastroesophageal Junction Adenocarcinoma Therapeutics Market: Size, Share, Scope & Forecast 2026–2034 April 8, 2026 Lalit Japan Gastroesophageal Junction Adenocarcinoma Therapeutics Market was valued at USD 1.5 Billion in 2024 and is estimated to reach USD 3.2 Billion by 2033, growing at a CAGR of 9.2%…